United Therapeutics Corporation (UTHR) Total liabilities 2016–2025
United Therapeutics Corporation (UTHR) total liabilities at each fiscal year-end, per SEC filings.
$783.8MFY2025 · since FY2016: $463.4M → $783.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $783.8M | -14.8% |
| FY2024 | $920.0M | -22.2% |
| FY2023 | $1.2B | -5.3% |
| FY2022 | $1.2B | +3.1% |
| FY2021 | $1.2B | -0.8% |
| FY2020 | $1.2B | +7.7% |
| FY2019 | $1.1B | +91.0% |
| FY2018 | $593.2M | -21.8% |
| FY2017 | $758.4M | +63.7% |
| FY2016 | $463.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice